Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FK 506: monitoring in plasma or in whole blood?

Literature DB >> 1721263

FK 506: monitoring in plasma or in whole blood?

A J Beysens¹, R M Wijnen, G H Beuman, J van der Heyden, G Kootstra, H van As.

Abstract

Entities: Chemical

Mesh：

Substances：
Tacrolimus

Year: 1991 PMID： 1721263

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients.

Authors: Nayoung Han; Hwi-yeol Yun; Jin-yi Hong; In-Wha Kim; Eunhee Ji; Su Hyun Hong; Yon Su Kim; Jongwon Ha; Wan Gyoon Shin; Jung Mi Oh
Journal: Eur J Clin Pharmacol Date: 2012-06-02 Impact factor: 2.953

Review 2. Immunosuppressive drugs in renal transplantation. A review of the regimens.

Authors: J M Barry
Journal: Drugs Date: 1992-10 Impact factor: 9.546

3. Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.

Authors: Katherine A Barraclough; Nicole M Isbel; Carl M Kirkpatrick; Katie J Lee; Paul J Taylor; David W Johnson; Scott B Campbell; Diana R Leary; Christine E Staatz
Journal: Br J Clin Pharmacol Date: 2011-02 Impact factor: 4.335

Review 4. The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors: S M Tsunoda; F T Aweeka
Journal: Clin Pharmacokinet Date: 1996-02 Impact factor: 6.447

5. Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment.

Authors: Katalin Dittrich; Ina Knerr; Wolfgang Rascher; Jörg Dötsch
Journal: Pediatr Nephrol Date: 2006-05-09 Impact factor: 3.714

FK 506: monitoring in plasma or in whole blood?

1. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients.

Review 2. Immunosuppressive drugs in renal transplantation. A review of the regimens.

3. Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.

Review 4. The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

5. Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment.

Review 6. Interpreting tacrolimus concentrations during pregnancy and postpartum.

Review 7. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

8. Pharmacokinetics of tacrolimus during pregnancy.

Review 9. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Review 10. Clinical pharmacokinetics of tacrolimus.